Package Leaflet: Information for the User
Estiripentol Billev 250 mg hard capsules EFG
Estiripentol Billev 500 mg hard capsules EFG
Read all of this leaflet carefully before your child starts taking this medicine because it contains important information for you.
Contents of the package leaflet
Estiripentol, the active substance of Estiripentol Billev, belongs to a group of medicines called antiepileptics.
It is used in combination with clobazam and valproate (other antiepileptic medicines) to treat a certain form of epilepsy called severe myoclonic epilepsy of infancy (Dravet syndrome) that affects children. Your child's doctor has prescribed this medicine to help treat epilepsy.
Do not give Estiripentol Billev to your child if:
Warnings and precautions
Consult your child's doctor or pharmacist before giving Estiripentol Billev to your child:
Other medicines and Estiripentol Billev
Tell your child's doctor or pharmacist if your child is taking, has recently taken, or might take any other medicines.
Tell your doctor if your child is taking any of the following medicines:
phenobarbital, primidone, phenytoin, carbamazepine, diazepam.
midazolam or triazolam (medicines used to reduce anxiety and insomnia – combined with estiripentol, they can cause significant drowsiness in your child);
chlorpromazine (used for mental illnesses such as psychosis).
Taking Estiripentol Billev with food and drinks
Do not take estiripentol with milk or dairy products (yogurt, creamy cheeses, etc.), fruit juices, fizzy drinks, or foods and drinks that contain caffeine or theophylline (e.g., cola, chocolate, coffee, tea, or energy drinks).
Pregnancy and breastfeeding
If your daughter is pregnant or breastfeeding, thinks she may be pregnant, or plans to become pregnant, consult her doctor before taking this medicine.
During pregnancy, antiepileptic treatment should not be interrupted.
Breastfeeding is not recommended during treatment with this medicine.
Driving and using machines
This medicine can cause drowsiness in your child.
Your child should not operate tools or machines or drive if they are affected in this way. Consult your child's doctor.
Estiripentol Billev contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per capsule; i.e., it is essentially "sodium-free".
Your child should take these capsules exactly as their doctor has told them. If in doubt, consult their doctor or pharmacist again.
Dose
The doctor will adjust the dose according to your child's age, weight, and condition, usually 50 mg per day per kilogram of body weight.
When to take Estiripentol Billev
Your child should take this medicine two or three times a day at regular intervals as indicated by their doctor: for example, in the mornings, at noon, and at bedtime to cover the night and daytime periods.
Dose adjustment
Dose increases should be gradual, replacing, over several weeks, the doses of other antiepileptic medicines, which will be reduced at the same time. Your child's doctor will inform you of the new dose of the other antiepileptic medicines.
If you think the effect of this medicine is too strong or too weak, consult your child's doctor or pharmacist. The doctor will adjust the dose according to your child's condition.
In case of side effects, consult your child's doctor, as it may be necessary to adjust the dose of this medicine and the other antiepileptic medicines.
There are slight differences between the capsules and the oral suspension powder of Estiripentol Billev. Please consult your doctor if your child experiences any problems when switching from capsules to oral suspension powder or vice versa. If switching between capsule and powder formulations, it should be done under the strict supervision of your child's doctor.
In case of vomiting in the first minutes after taking, it is considered that the medicine has not been absorbed and a new dose should be given.
However, the situation changes if vomiting occurs more than an hour after taking the medicine, as estiripentol is rapidly absorbed.
If this is the case, it will be considered that a significant fraction of the administered dose has been systemically absorbed in the digestive tract. Therefore, there will be no need to take a new dose to adjust the next dose.
How to take the capsules of Estiripentol Billev
To ensure that the patient takes the complete amount of powder, it is preferable not to open the capsule and to swallow it as a single oral dose. Your child should take Estiripentol Billev with food and not on an empty stomach. To know which foods and drinks to avoid, see the previous section "Taking Estiripentol Billev with food and drinks".
If your child takes more Estiripentol Billev than they should
Consult your child's doctor if you know or think your child has taken more of the medicine than they should.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
If your child forgets to take Estiripentol Billev
It is important that your child takes this medicine regularly at the same time every day. If your child forgets to take a dose, they should take it as soon as you remember, unless it is time for the next dose. In that case, continue with the next dose as usual. Your child should not take a double dose to make up for forgotten doses.
If your child stops taking Estiripentol Billev
Your child must not stoptaking this medicine unless their doctor tells them to. Stopping treatment can cause a seizure crisis.
If you have any other questions about the use of this medicine, ask your child's doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common side effects(may affect more than 1 in 10 people):
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Rare side effects(may affect up to 1 in 1,000 people):
To eliminate these side effects, your child's doctor may need to vary the dose of estiripentol or one of the other medicines prescribed to your child.
Reporting of side effects
If your child experiences any side effects, consult your child's doctor or pharmacist, even if they are possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System: https://www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not give this medicine to your child after the expiry date stated on the label and carton. The expiry date is the last day of the month stated.
Store in the original package to protect from light. This medicine does not require any special storage temperature.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Estiripentol Billev
Estiripentol Billev 250 mg: each capsule contains 250 mg of estiripentol.
Estiripentol Billev 500 mg: each capsule contains 500 mg of estiripentol.
Capsule content: sodium carboxymethyl starch type A, povidone K30, sodium lauryl sulfate, and magnesium stearate.
Capsule shell: gelatin, titanium dioxide (E171), erythrosine (E127) (only Estiripentol Billev 250 mg), and indigo carmine (E132) (only Estiripentol Billev 250 mg).
Printing ink: shellac (E904), propylene glycol (E1520), iron oxide black (E172), and potassium hydroxide.
Appearance of the product and contents of the pack
Estiripentol Billev 250 mg is a hard, opaque, pink capsule with "SP250" printed on the body.
Estiripentol Billev 500 mg is a hard, opaque, white capsule with "SP500" printed on the body.
Estiripentol Billev is supplied in child-resistant closure bottles containing 30, 60, or 90 capsules.
Not all pack sizes may be marketed.
Estiripentol Billev is also available as a powder for oral suspension in sachets of 250 mg and 500 mg.
Marketing authorisation holder
Billev Pharma ApS
Slotsmarken 10
2970 Hoersholm
Denmark
Manufacturer
Misom Labs Limited
Malta Life Sciences Park
LS2.01.06, Industrial Estate
San Gwann
SGN 3000
Malta
Date of last revision of this leaflet:05/2024
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS): http://www.aemps.gob.es/